| Active ingredient (INN) | Ambrisentan |
|---|---|
| Brand names | Viatris |
| ATC level 5 | C02KX02 |
| ATC level 4 | C02KX |
| Therapeutic category | Auto-created by Therapeutic Goods Administration — Medicine Shortages scraper |
| Controlled substance | No |
| Marketing-authorisation holders | Alphapharm Pty Ltd, Sandoz Pty Ltd, GlaxoSmithKline Australia Pty Ltd, Cipla Australia Pty Ltd +1 more |
| Registrations on file | 16 |
| Patient information leaflet (PIL) | Not on file |
| Summary of product characteristics (SPC) | Not on file |
| Product | Strength | Form | Market | MA holder | Status |
|---|---|---|---|---|---|
| Viatris | 10 mg | — | 🇦🇺 AU | Alphapharm Pty Ltd | Active |
| Sandoz | 5 mg | — | 🇦🇺 AU | Sandoz Pty Ltd | Active |
| Sandoz | 10 mg | — | 🇦🇺 AU | Sandoz Pty Ltd | Active |
| Msn | 5 mg | — | 🇦🇺 AU | — | Active |
| Msn | 10 mg | — | 🇦🇺 AU | — | Active |
| VOLIBRIS ambrisentan | 5mg | — | 🇦🇺 AU | GlaxoSmithKline Australia Pty Ltd | Active |
| VOLIBRIS ambrisentan | 10mg | — | 🇦🇺 AU | GlaxoSmithKline Australia Pty Ltd | Active |
| PULMORIS ambrisentan | 10 mg | — | 🇦🇺 AU | Cipla Australia Pty Ltd | Active |
| PULMORIS ambrisentan | 5 mg | — | 🇦🇺 AU | Cipla Australia Pty Ltd | Active |
| Cipla | 10 mg | — | 🇦🇺 AU | Cipla Australia Pty Ltd | Active |
| Cipla | 5 mg | — | 🇦🇺 AU | Cipla Australia Pty Ltd | Active |
| AMBRICIP ambrisentan | 10 mg | — | 🇦🇺 AU | Cipla Australia Pty Ltd | Active |
| AMBRICIP ambrisentan | 5 mg | — | 🇦🇺 AU | Cipla Australia Pty Ltd | Active |
| Viatris | 5 mg | — | 🇦🇺 AU | Alphapharm Pty Ltd | Active |
| Ambrisentan | 5mg/1 | tablet | 🇺🇸 US | Mylan Pharmaceuticals Inc. | Active |